From the Journals
Wearable Trackers: These Activity Metrics Drive Calorie Burn
-
By
-
March 19, 2026
-
4 min
By
March 19, 2026
Semaglutide 7.2 mg achieved 20.7% mean weight loss in STEP UP trials.
March 19, 2026
“Insurance coverage of CGM is frequently identified in the literature as a barrier to CGM access."
by Alun Evans
March 18, 2026
Ultrasound based AI–assisted diagnostic systems “demonstrated high clinical potential."
March 18, 2026